The reticulocyte count is, conceptually at least, the simplest method to assess erythropoiesis. The traditional method enploying supra-vital dyes such as new methylene blue, cresyl blue or azure B and visual microscopy is time-consuming, poorly standardised and extremely imprecise. The major causes of imprecision arise from interobserver variation in the definition of a reticulocyte and the statistical unreliability of the counting procedure. Single measurements at low number level with this method are hardly meaningful. Studies have, however, shown that with repeated but time-consuming procedures both the reliability and the precision can be improved.
INTRODUCTION
The reticulocyte count is familiar to all haematologists and represents in the minds of most, a labour intensive, imprecise laboratory procedure of limited clinical utility. Is this a fair judgement? Regrettably, in routine practice, with widely performed methods using supravital stainsandwith current attitudes the answer must be affirmative. But let us step back and review the requirements which any diagnostic test must fulfil. First, the problem to be solved must be defined in a clear and unambiguous manner establishing proof of clinical utility.
Secondly, those properties and specifications which the test must meet require identification and finally benefit-cost analysis must be undertaken. These must be analysed for reticulocyte counting when the procedure can be performed in a standardized reproducible manner.
The clinical usefulness of reticulocyte counting is established and may be more extensive than many believe. It may be smmrized as follows: the reticulocyte count demonstrates what is happening to erythropoiesis and not what happened days, weeks or months ago. The procedure is useful in the following circumstances:
Distinction between hyper-from hypo-proliferative anaemias Monitoring response to treatment in haematinic deficiency Monitoring for accidental or therapeutically induced myelosuppression Monitoring for recovery in myelosuppression for any cause and following bone marrow transplantation Monitoring of premature infants
The reticulocyte count therefore can produce information which is of value in both diagnosis and treatment.
There is little published information on the frequency with which the reticulocyte count is abnormal in routine practice. A small pilot study in the author's laboratory using a flow cytanetry de ice gives some indication that the reticulocyte count, expressed as an absolute nunber (x 10 /L), may be abnormal as often as the platelet count and the latter has long been accepted as a first line haematological measurement. The results of this survey are given in table 1.
There were 100 patients in each group. The normal ranges on which these data were based were calculated using a Gaussian distribution rather than the lognormal distribution ret'culocytes mean value of 50 x 10 /L and in healthy females 27-86 x 109/L with a mean value of 57 x 10 /L (measurements performed using the Sysmex RIOOO Reticulocyte Counter).
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are thought to folly. The range found in healthy male subjects was 14-85 x 10 4 -' /L wlt a 
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the r e l a t i v e proportions f o r
0.1%
Extended network o f loose reticulum;
7.0%
Scattered granules with residual reticulum;
32.0%
Scattered granules;
61.0%
SUPRAVITAL STAINING METHODS
Supravital staining and counting by microscopy i s widely practised and i s the method which has gained f o r the procedure the poor reputation i t currently possesses. Imprecision i n routine practice can be judged from r e s u l t s i n external proficiency exercises which range from CVs o f 30-40% (refs. 
1,Z).
This i s c l e a r l y unacceptable.
The increasing c l i n i c a l emphasis on reticulocyte counting a t low l e v e l s demands the development o f methods o f improved precision and accuracy a t these low levels.
How can t h i s be improved and accuracy assured? (1 1 I t i s reconmended that reticulocyte counts be expressed i n absolute numbers rather than proportion.
So expressed, r e s u l t s are more informative especially low r e s u l t s and additionally correction f o r anaemia becomes unnecessary.
When the combined proportion o f Heilmeyer Stages I and I 1 exceeds lo%, ' s h i f t ' correction i s also required. A reticulocyte count corrected both f o r PCV and maturation time i s termed the reticulocyte production index. With increasing anaemia associated with increased erythrop o i e t i n production, the maturation t i m e o f marrow reticulocytes progressively shortens from a normal o f 3.5 t o 1.5 days or less ( r e f . 8). Conversely the reticulocytes i n the peripheral blood persist, f o r a longer t i m e when anaemia i s present. 
Method standardization
Standardization of methodology is required. Scrutiny of existing texts on practical haematology procedures reveal small but possibly important and measurable method differences.
Sample size
The reticulocyte count is normally approximately 1% or 10 reticulocytes per 1000 RBC. It is usually recomnended that visual counts are based on evaluation of 1000RBC and it must be conceded that even this modest rule is not always followed in the routine laboratory. Even counts of 1000 red cells are inherently imprecise due to sampling error since reticulocytes are rare events, the statistics of which generally follow the Poisson distribution. The only way in which to improve the statistics of a procedure such as this is to count more cells. The statistical requirements make a strong case for automated methods for reticulocyte counting but at the same time render good comparison between automated procedures and visual counts difficult unless the sample size of the latter approaches that of the former. For statistical validity 30,000 red cell events are desirable. This problem has been addressed by ICSH (ref. 6 ) . Although currently rated as a recomnended or selected method, this could be developed into a reference method.
To attain the sample size required for statistical validity a microscope area reducing device is necessary. This device standardizes both the reduced and total areas in which cells should be counted. The 'Miller disc' is recomnended by both NCCLS (ref. 5) and ICSH (ref. 6 ) and contains a small square within a large square. The small square is 1/9th the area of the large square, therefore assuming even distribution of cells on the blood smear, the number of cells in the small square is 1/9th of the number of cells in the large square.
Before use, it is advisable to check the calibration of the graticule by obtaining the average red cell counts in 5 large squares and in 5 small squares to establish that the proportion is 9. This will only apply when blood cells are evenly spread on the slide. Proportional counting is then carried out, i.e. the number of reticulocytes in the entire square divided by the number of red cells in the small square in consecutive fields until the requisite number of red cells is attained.
To determine the total number of red cells to be counted ICSH (ref. 6 ) recomnends a 'target' CV concept. Calculation of the CV is from the following equation:
Where CV = coefficient of variation; p = proportion of reticulocytes; n = total number of cells.
Thus the number of cells to be counted to achieve coefficients of variation of 51 and 10% is shown in table 3.
AUTOMATION OF RETICULOCYTE COUNTING
To date automation of reticulocyte counting has developed along two routes. The development of computerized image analysis instruments in the 1970s for peripheral blood smear analysis provided an opportunity to automate reticulocyte counting. This was achieved in three comnercial instruments. Reasonable agreement with microscope counts was achieved (ref. lo), but performance was highly stain specific. The introduction of these systems provided an opportunity to standardize methodology with considerable improvement in precision; however, since very few cells were evaluated (up to 500) sampling error continued to exist.
The emergence of flow cytometers using RNA fluorochromes which produced fluorescence proportional to the amount of RNA present in the cell resulted in a more significant advance. The advantages of the flow cytometry method are several-fold and include reduction in imprecision (10,000-30,000 red cells evaluated), improved throughput and reduction in labour costs for the procedure. Statements on improvement in accuracy are still being corroborated because of difficulty in specifying a reference method against which appropriate comparability studies can be performed.
The various fluorescent dyes currently used in flow cytometry devices are listed in 
Mean bias
The f i r s t f i v e dyes require a t least 30 minutes incubation f o r uptake thus making the techniques suitable only for batch analyses.
Ethidium bromide, on the other hand, a t r e l a t i v e l y high pH enters i n t a c t c e l l s within a few minutes.
Likewise, auramine 0, the dye used i n the Sysmex* R1000, requires only a few seconds, permitting a fast throughput for t h i s instrument.
Since r e t i c u l o c y t e counts are performed on whole blood specimens, careful threshold settings are required t o exclude autofluorescing, mature red c e l l s , p l a t e l e t s , white and other nucleated blood cells.
Conversion o f red c e l l / r e t i c u l o c y t e scattergram data t o a d i s t r i b u t i o n histogram t o set a threshold and calculate the proportion o f reticulocytes currently i s a problem which may account f o r differences on d i f f e r e n t systems.
This w i l l only be f i n a l l y resolved when an appropriate d i s t r i b u t i o n model i s defined and a satisfactory material standard f o r r e t i c u l o c y t e counting becunes available.
A major advantage o f automated flow cytometry arises from the proportionality o f fluorescence t o the amount o f RNA i n the reticulocyte.
Increasing fluorescence inversely correlates with the Heilmeyer Stage nunber, i.e. the most mature reticulocytes have the least fluorescence and vice versa.
Clearly increasing fluorescence i n the reticulocyte populations can be used t o i d e n t i f y ' s h i f t ' forms and thus can give a measure o f reticulocyte imnaturity.
Various workers are now using the so-called 'reticulocyte maturity index' although t h i s term i s somewhat ambiguous and m i g h t be more correctly expressed as the reticulocyte imnaturity index. The Sysmex RlOOO reticulocyte counting instrument assesses reticulocyte imnaturity by d i v i d i n g the reticulocyte area by two v e r t i c a l discriminators i n t o low fluorescence r a t i o (LFR), the most mature forms, middle (WR) and high fluorescence (HFR) areas, the l a s t being the most inmature form.
The c l i n i c a l u t i l i t y o f data on the maturation o f the reticulocyte i s currently s t i u l a t i n g intense interest.
EVALUATION OF THE SYSMEX R l O O O
A nuaber of evaluations o f t h i s system have now been published (refs. 11,12,13) . 
Effect of dilution (linearity)
This i s presented i n table 5. Each reticulocyte absolute count and reticulocyte percentage represents the mean o f four measurements a t each d i l u t i o n . 
intercepts are different
CONCLUSIONS
There is a clear place for reticulocyte counting in the modern laboratory and automated devices produce counts at rates of up to 60/h with impressively low imprecision. The clinical value of reticulocyte counting particularly at low levels is being increasingly recognised.
Counts must be expressed in absolute nmbers. Reticulocyte maturation measurements may well have clinical value. Detailed assessment of the frequency with which abnormal counts appear and the clinical actions so stimulated will determine the future of this automated measureuent.
Whether or not the reticulocyte count becomes a first line
